Results 241 to 250 of about 1,943,367 (358)

The Effect of N-Acetylcysteine (NAC) on Neurometabolites and Cognitive Function in Adults With Alcohol Use Disorder: A Preliminary Randomized Controlled Trial. [PDF]

Neuropsychopharmacol Rep
Dunbar KY, Dali G, DeMayo MM, Logge W, Hurzeler T, Kelly C, Watt J, Squeglia LM, Kirkland AE, Haber PS, Morley KC.   +10 more
europepmc   +1 more source

A double-blind, placebo-controlled, randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis—a north central cancer treatment group study

, 1994
Robert L. Foote, CL Loprinzi, A R Frank, Judith R. OʼFallon, Sunil Gulavita, Hamed H. Tewfik, Mike Ryan, Jenny Earle, P. Novotny   +8 more
openalex   +1 more source

Cognitive Impairment in Multiple Sclerosis: The Role of Clinical and Sociodemographic Factors ‐ A Systematic Review and Meta‐Analysis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive impairment (CI) affects the quality of life in multiple sclerosis (MS). Identifying influencing factors is key to improving CI monitoring. This systematic review and meta‐analysis examines clinical and sociodemographic variables impacting the cognitive screening Symbol Digit Modalities Test (SDMT) performance across MS ...
Katalin Lugosi, Marie A. Engh, Tamás Kói, Zsolt Molnár, Gábor Csukly, Klaudia Horváth, Emma Hargitai, Péter Hegyi, Zsolt Mezei   +8 more
wiley   +1 more source

A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. [PDF]

, 1996
Ann E. Taylor, Judith Adams, Jan Mulder, K A Martin, Patrick M. Sluss, W F Crowley   +5 more
openalex   +1 more source

NR4A1 Exerts Pro‐Tumor Role in Glioblastoma via Inducing xCT/GPX4‐Regulated Ferroptosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Purpose This study investigates NR4A1's paradoxical roles in glioblastoma (GBM) progression, focusing on its mechanistic link to ferroptosis regulation. We aimed to resolve conflicting reports of NR4A1 as both an oncogene and a tumor suppressor by defining its transcriptional control over xCT/GPX4‐mediated iron homeostasis and its clinical ...
Peng Tao, Shikuan Din, Zhengkang Fu, Qian Sun, Xiwei Zhu, Yuxin Wei, Huan Qu, Xinyi Zhang, Jiaxuan Liu, Chuhua Fu, Qianxue Chen   +10 more
wiley   +1 more source

Virtual reality simulation for learning minimally invasive endodontics: a randomized controlled trial. [PDF]

BMC Med Educ
Srakoopun C, Suebnukarn S, Haddawy P, Kaluschke M, Weller R, Yin MS, Aguilar P, Phumpatrakom P, Pinchamnankool K, Budsaba K, Zachmann G.   +10 more
europepmc   +1 more source

The influence of dietary and nondietary calcium supplementation on blood pressure An updated metaanalysis of randomized controlled trials

, 1999
Lauren E. Griffith
openalex   +1 more source

A double-blind, randomized, placebo-controlled trial of prostaglandinE1 in liver transplantation [PDF]

, 1995
Keith S. Henley, Michael R. Lucey, Daniel P. Normolle, Robert M. Merion, Ian D. McLaren, Bruce A. Crider, Donald S. Mackie, Victoria Shieck, Timothy T. Nostrant, Kimberly Brown, Darrell A. Campbell, J. M. Ham, Henry D. Appelman, Jeremiah G. Turcotte   +13 more
openalex   +1 more source

Pre‐Diagnostic Features of Multiple Sclerosis in a Diverse UK Cohort: A Nested Case–Control Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Many patients with Multiple Sclerosis (MS) experience nonspecific symptoms prior to diagnosis. This period—the 'MS prodrome'—has been described in socio‐economically homogeneous cohorts to date. It remains unclear to what extent events prior to an MS diagnosis differ according to social determinants of health. Methods We conducted a
Pooja Tank, Benjamin M. Jacobs, Jonathan Bestwick, Ruth Dobson   +3 more
wiley   +1 more source

Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer Data

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Therapeutic development for mitochondrial diseases, rare genetic disorders with pathogenic defects of oxidative phosphorylation, is hindered by unsatisfactory outcome measures. To address this problem, we provide the first clinical application of a novel, bias‐adjusted outcome measure of acceleration across a range of subjects ...
Ian W. McKeague, Kristin Engelstad, Yue Ge, Amber Tucker, Shufang Li, Jasim Uddin, Ziwei Zhao, John L. P. Thompson, Michio Hirano   +8 more
wiley   +1 more source